NYSE · DOCS
Doximity, Inc.
$32.75-$0.88 (-2.62%)
Doximity, Inc.’s quoted price sits in the lower half of its reported 52-week range, 51.19% below the high.
Loading market information…
OTC · OTRKQ · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Ontrak, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.88% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Ontrak, Inc.’s next earnings report is currently expected on Nov 12, 2026, with estimated earnings per share of -$33.26. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Ontrak, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Ontrak, Inc. is a virtualized healthcare company that leverages artificial intelligence and telehealth to deliver services, including in-person components, to health plans and other third-party payors across the United States. Its sophisticated, technology-driven platform can predict which individuals with chronic conditions are likely to benefit from behavioral modifications. It then recommends personalized, effective care pathways designed for patient adherence, actively engaging and guiding them throughout their treatment journey. The cornerstone of its offerings is the technology-enabled OnTrak program, which provides comprehensive healthcare solutions for members struggling with behavioral conditions that either cause or worsen chronic medical issues like diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease (COPD), and congestive heart failure. OnTrak integrates a blend of evidence-based psychosocial and medical interventions, accessible both in-person and through telehealth. This is complemented by dedicated care coaching and local community care coordinators, who specifically work to mitigate the social and environmental factors affecting health. Founded in 2003, the company operated as Catasys, Inc. until its rebranding to Ontrak, Inc. in July 2020. Its corporate headquarters are located in Henderson, Nevada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:09 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2024 |
|---|
| Apr 16, 2024 |
| -$4.35+83.0% vs estimate |
| $3.54M+31.07% vs estimate |
| Q3 2023 | Nov 14, 2023 | -$24.14+34.92% vs estimate | $3.72M-7.98% vs estimate |
|---|
| Q2 2023 | Aug 9, 2023 | -$24.89+47.41% vs estimate | $2.96M-60.53% vs estimate |
|---|
THE ANALYST VIEW
5 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$32.75-$0.88 (-2.62%)
Doximity, Inc.’s quoted price sits in the lower half of its reported 52-week range, 51.19% below the high.
$3.42-$0.12 (-3.32%)
GoodRx Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 12.02% below the high.
$18.55-$1.10 (-5.6%)
Omada Health’s quoted price sits in the upper half of its reported 52-week range, 29.01% below the high.
$5.25$0.00 (0.0%)
Talkspace, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$13.19-$1.79 (-11.95%)
American Well Corporation’s quoted price sits in the upper half of its reported 52-week range, 12.99% below the high.
$1.71-$0.08 (-4.47%)
Health Catalyst, Inc.’s quoted price sits in the lower half of its reported 52-week range, 49.11% below the high.
$0.53-$0.01 (-1.45%)
HeartBeam, Inc.’s quoted price sits in the lower half of its reported 52-week range, 86.72% below the high.
$4.27-$0.10 (-2.32%)
OneMedNet Corporation’s quoted price sits in the lower half of its reported 52-week range, 81.44% below the high.
